(Press-News.org) Researchers have found that SSRI (Selective Serotonin Reuptake Inhibitors) antidepressants have the potential to improve certain cognitive functions, such as verbal memory. They measured brain function in patients before and after taking the SSRI escitalopram and correlated this to a drop in the level of one of the serotonin receptors in the brain and to cognitive improvements during treatment. This work is presented for the first time at the ECNP Conference in Milan, after recent publication in the journal Biological Psychiatry.
Serotonin is often described as a ‘feel good’ chemical, and higher levels of serotonin circulating in the brain contribute to a sense of well-being, and can ease clinical depression in most sufferers. There are several serotonin receptors in the brain, and all will serve to regulate well-being by regulating circulating serotonin’s interaction with the brain. However, this work concentrated on only one serotonin receptor, the 5HT4 receptor.
The researchers began by scanning the brains of 90 depressed patients, to measure the quantity of 5HT4 receptor which serotonin binds to. At the same time, patients were given a series of tests to measure mood and cognitive abilities.
Patients were given daily doses of escitalopram, and at the end of an 8-week period, 40 patients were rescanned to measure the quantity of 5HT4 receptor in the brain. The mood of the patients had improved, but the team also found that the levels of 5HT4 receptor had dropped by around 9% possibly due to adaptations to increased levels of serotonin. When they asked these patients to undertake more cognitive tests, they found that their performance had improved, so that the less the 5HT4 receptor had changed the better the cognitive outcome. This phenomenon was particularly prominent for the ability to recall words.
“This is potentially significant” said researcher Vibeke Dam (Copenhagen University Hospital, Rigshospitalet, Denmark), “It seems that the SSRI medication contributes to an improvement on cognitive function, at the same time as helping improve mood. Our work ties the improvement in cognitive function to the specific 5HT4 receptor and suggest that direct serotonin 4 receptor stimulation may be in important pro-cognitive target to consider in optimizing outcomes of antidepressant treatment. It also reinforces the idea that serotonin is crucial to mood improvement.
Co-researcher Vibe Froekjaer (Copenhagen University Hospital, Rigshospitalet, Denmark), added, “This is a first result, so we need to do a lot more work to look at the implications. Poor cognitive function is very hard to treat efficiently and may require extra treatment. This work points to the possibility of stimulating this specific receptor so that we can treat cognitive problems, even aside from whether or not the patient is has overcome the core symptoms of depression”.
The researchers note that this was a real-world study, so there is no placebo control.
The team’s next step is to treat patients with drugs which specifically stimulates the 5HT4 receptor to see the effect on cognitive function; interestingly, serotonin is also found in the gut, and there are drugs available to treat irritable bowel syndrome which specifically bind to and stimulate 5HT4 , which the team may repurpose in these trials.
Commenting, Professor Philip Cowen, Professor of Psychopharmacology at the University of Oxford said:
“In the context of recent controversies about the role of brain serotonin in clinical depression, it is noteworthy that the PET studies of the Copenhagen Group provide unequivocal evidence that brain 5-HT4 receptors are decreased in unmedicated depressed patients. Their work also demonstrates the intimate role of brain 5-HT4 receptors in cognitive function. This confirms recent work from Oxford showing that the 5-HT4 receptor stimulant, prucalopride – a drug licensed for the treatment of constipation- improves memory in both healthy participants and people at risk of depression”.
This is an independent comment, Professor Cowen was not involved in this work.
Article in Press, Biological Psychiatry: https://www.biologicalpsychiatryjournal.com/article/S0006-3223(24)01537-3/abstract
Please note that all comments derive from the conference, they do not appear in the publication.
ENDS
END
Cambridge University has today released a groundbreaking report outlining a five-year roadmap to help the aviation sector achieve net-zero climate impact by 2050.
Despite ambitious pledges from governments and industry, the aviation sector remains significantly off course in its efforts to achieve net-zero emissions by 2050. The report, titled “Five Years to Chart a New Future for Aviation,” outlines four 2030 Sustainable Aviation Goals—specific, actionable steps that must be initiated immediately and completed within five years if the aviation sector is to be on track to achieve net-zero by 2050.
The 2030 Goals outlined in the report are:
Accelerating the deployment ...
A direct comparison between the experimental psychedelic drug psilocybin and a standard SSRI antidepressant shows similar improvement of depressive symptoms, but that psilocybin offers additional longer-term benefits.
The comparison, between psilocybin (the active ingredient in “magic mushrooms”) and the SSRI escitalopram gave similar long-term improvements in depressive symptoms over a 6-month period, however patients taking psilocybin also reported better psychosocial functioning including experiencing a greater sense of meaning ...
Milan, Italy: Around 80% of women suffer from “baby blues” after the birth of their child. Normally this is a brief period of feeling down which disappears in a few days. But around 1 woman in 7 develops postpartum depression; this is a more serious depression which can affect how mothers bond with their baby and can have long-term consequences. These women seem unable to regulate the negative emotions which can follow giving birth.
Now a group of European Reesearchers have found that in healthy pregnant women activity in a specific area deep in the brain is linked to regulation of negative ...
LOS ANGELES – Among patients with early-stage breast cancer treated with adjuvant endocrine therapy (AET), symptoms related to sexual health were associated with decreased adherence to treatment in Black women, according to results presented at the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held September 21-24, 2024.
Patients with hormone receptor-positive breast cancer are commonly given endocrine therapy—treatments that block estrogen signaling in the breast—after receiving surgery, radiation, or chemotherapy. The recommended regimen for AET ...
LOS ANGELES – In recent years, Black patients with triple-negative breast cancer (TNBC) received immunotherapy at significantly lower rates than white patients, according to results presented at the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held September 21-24, 2024.
Black women are disproportionately affected by TNBC, an aggressive subtype of breast cancer defined by the lack of three cell surface receptors. The absence of these receptors means that patients with TNBC are ineligible for many of the molecularly targeted therapies used to treat other breast cancer subtypes, explained ...
LOS ANGELES – The Affordable Care Act (ACA) has led to increased guideline-concordant care for colon cancer among non-white patients, patients from rural areas, and patients from the most deprived neighborhoods in Pennsylvania, according to results presented at the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held September 21-24, 2024.
“The ACA was the largest change to the health insurance system in the United States since the introduction of Medicare and Medicaid ...
A study of stigma against LGBTQ (lesbian, gay, bisexual, transgender and queer) people in British Society has shown that there is less stigma against these groups that might be expected from social and media perceptions. The same study looked at stigma against people with mental health problems and discovered that they continue to experience higher levels of stigma. This work will be presented at the ECNP conference in Milan. This is an advance press release see note below.
Researcher Professor Karen Ersche (University of Cambridge) said, “Our aim was to look at the level of stigma against LGBTQ people in British society, and also to look at stigma ...
Cells are highly controlled spaces that rely on every protein being in the right place. Many diseases, including cancers and neurodegenerative disorders, are associated with misplaced proteins. In some cancers, for instance, a protein that normally stands watch over DNA replicating in the nucleus is sent far from the DNA it is meant to monitor, allowing cancers to grow.
Steven Banik, assistant professor of chemistry in the School of Humanities and Sciences and institute scholar at Sarafan ChEM-H at Stanford University, and his lab have developed a new method to help force misplaced proteins back to their proper homes within cells. The method ...
In a study published July 29 in Advanced Materials, University of Texas at Dallas researchers found that X-rays of the kidneys using gold nanoparticles as a contrast agent might be more accurate in detecting kidney disease than standard laboratory blood tests. Based on their study in mice, they also found that caution may be warranted in employing renal-clearable nanomedicines to patients with compromised kidneys.
Before administering renal-clearable drugs, doctors routinely check a patient’s kidney function by testing their ...
The Texas A&M University School of Public Health and USAging have been awarded the 2024 Immunization Neighborhood Champion Award by the U.S. Centers for Disease Control’s National Adult and Influenza Immunization Summit. Matthew Lee Smith, PhD, professor at the School of Public Health, leads the school’s involvement as a founding member of USAging’s Aging and Disability Vaccination Collaborative (ADVC).
Announced as respiratory illness season is ramping up in the United States, this honor recognizes Smith’s work in support of ADVC’s efforts ...
